Pharmacy worker practices related to use of misoprostol for abortion in one Mexican state

Contraception

Volumn 79, Issue 6, 2009, Pages 445-451

  Billings, Deborah L ^a   Walker, Dilys ^b   Mainero del Paso, Guadalupe ^c   Clark, Kathryn Andersen ^d   Dayananda, Ila ^a  

^a National Institute of Public Health ^*  (United States)

^b Ipas   (Mexico)

^c IPAS   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Abortion; Mexico; Misoprostol; Mystery clients; Pharmacy

Indexed keywords

MISOPROSTOL;

ARTICLE; DRUG COST; DRUG INDICATION; DRUG MARKETING; DRUG USE; HUMAN; INDUCED ABORTION; MEDICAL INFORMATION; MEXICO; PHARMACIST ATTITUDE; PHARMACY; PHARMACY TECHNICIAN; PRESCRIPTION; PROFESSIONAL PRACTICE; RURAL AREA; URBAN AREA;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADULT; FEMALE; HUMANS; MALE; MEXICO; MISOPROSTOL; PHARMACIES; SELF MEDICATION;

EID: 67349247844     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.12.011     Document Type: Article

References (40)

1. PATH (Program for Appropriate Technology in Health). Increasing access to reproductive health services through pharmacists. Outlook 21 (2004) 1-6
2. Goel P., Ross-Degnan D., Berman P., and Soumeri S. Retail pharmacies in developing countries: a behavior and intervention framework. Soc Sci Med 42 (1996) 1155-1161
3. Leyva-Flores R., Bronfman M., and Erviti-Erice J. Clientes ficticios en farmacias: conducta prescriptiva de los dependientes de farmacias. J Social Adm Pharm 17 (2000) 151-158
4. Mayhew S., Khonde N., Pépin J., and Adjei S. Pharmacists' role in managing sexually transmitted infections: policy issue and options for Ghana. Health Policy Plann 16 (2001) 152-160
5. Finger W.R. Commercial sector can improve access. Network 18 (1998) 12
6. Blanchard K., Harrison T., and Sello M. Pharmacists' knowledge and perceptions of emergency contraception pills in Soweto and the Johannesburg central business district, South Africa. Int Fam Plann Perspect 31 (2005) 172-178
7. Igun U.A. Reported and actual prescription of oral rehydration therapy for childhood diarrhoeas by retail pharmacists in Nigeria. Soc Sci Med 39 (1994) 797-806
8. Ramos M.C., da Silva R.D., Gobbato R.O., et al. Pharmacy clerks' prescribing practices for STD patients in Porto Alegre, Brazil: missed opportunities for improving STD control. Int J STD AIDS 15 (2004) 333-336
9. Leyva-Flores R., Erviti-Erice J., Ramsey J., and Gasman N. Medical drug utilization patterns for febrile patients in rural areas of Mexico. J Clin Epidemiol 50 (1997) 329-335
10. Drug Utilization Research Group. Multicenter study on self-medication and self-prescription in six Latin American countries. Clin Pharmacol Ther 61 (1997) 488-493
11. Turner A., Ellertson C., Thomas S., and García S. Diagnosis and treatment of presumed STIs at Mexican pharmacies: survey results from a random sample of Mexico City pharmacy attendants. Sex Transm Infect 79 (2003) 224-228
12. Chalker J., Chuc N.T., Falkenberg T., and Tomson G. STD management by private pharmacies in Hanoi: practice and knowledge of drug sellers. Sex Transm Infect 76 (2000) 299-302
13. Bista P.P., Chaudhary P., Slanger T.E., and Khan M.H. The practice of STI treatment among chemists and druggists in Pokhara, Nepal. Sex Transm Infect 78 (2002) 223
14. Garcia P., Hughes J., Carcomo C., and Holmes K. Training pharmacy workers in recognition, management, and prevention of STDs: district-randomized controlled trial. WHO 81 (2003) 806-814
15. Costa S.H. Commercial availability of misoprostol and induced abortion in Brazil. Int J Gynaecol Obstet 63 (1998) S131-S139
16. Kroeger A., Ochoa H., Arana B., Diaz A., Rizzo N., and Flores W. Inadequate drug advice in the pharmacies of Guatemala and Mexico: the scale of the problem and explanatory factors. Ann Trop Med Parasitol 95 (2001) 605-616
17. Secretaría de Salud. Encuesta Nacional de Salud II (1994), Secretaría de Salud, México, DF
18. Angeles P., Medina M., and Molina J.F. Automedicación en población urbana de Cuernavaca, Morelos. Salud Pública Méx 34 (1992) 487-590
19. WHO. Unsafe abortion: global and regional estimates of incidence of unsafe abortion and associated mortality in 2003. 5th ed. (2007), WHO, Geneva, Switzerland
20. Sedgh G., Henshaw S., Singh S., Ahman E., and Shah I.H. Induced abortion: estimated rates and trends worldwide. Lancet 370 (2007) 1338-1345
21. Schiavon R., Polo G., and Troncoso E. Hoja Informativa. Aportes para el debate sobre la despenalización del aborto [accessed on March 18, 2008]. Available from: (2008). http://www.ipas.org/Publications/asset_upload_file73_3073.pdf
22. Coelho H.L., Teixeira A.C., Santos A.P., et al. Misoprostol and illegal abortion in Fortaleza, Brazil. Lancet 341 (1993) 1261-1263
23. Coelho H.L., Teixeira A.C., Cruz Mde F., et al. Misoprostol: the experience of women in Fortaleza, Brazil. Contraception 49 (1994) 202-220
24. Barbosa R.M., and Arilha M. The Brazilian experience with misoprostol. Stud Fam Plann 24 (1993) 236-240
25. Cohen J., Ortíz O., Llaguno S.E., Goodyear L., Billings D., and Martínez I. Reaching women with instructions on misoprostol use in a Latin American country. Reprod Health Matters 13 (2005) 84-92
26. Lara D., Abuabara K., Grossman D., and Diaz-Olavarrieta C. Pharmacy provision of medical abortifacients in a Latin American City. Contraception 74 (2006) 394-399
27. Pick S., Givaudan M., Cohen S., Alvarez M., and Collado M.E. Pharmacists and market herb vendors: abortifacient providers in Mexico City. In: Mundigo A.I., and Indriso C. (Eds). Abortion in the developing world (1999), Vistaar Publications, New Delhi 293-310
28. Madden J.M., Quick J., Ross-Degnan D., and Kafle K.K. Undercover careseekers: simulated clients in the study of health provider behavior in developing countries. Soc Sci Med 45 (1997) 1465-1482
29. Huntington D., and Schuler S.R. The simulated client method: evaluating client-provider interactions in family planning clinics. Stud Fam Plann 24 (1993) 187-193
30. Gemzell-Danielsson K., Marions L., Rodriguez A., Spur B.W., Wong P.Y., and Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 93 (1999) 275-280
31. Blanchard K., Shochet T., Coyaji K., Ngoc N.T.N., and Winikoff B. Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception 72 (2005) 91-97
32. Norman J.E., Thong K.J., and Baird D.T. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 338 (1991) 1233-1236
33. Carbonell J.L., Varela L., Velazco A., and Fernández C. The use of misoprostol for termination of early pregnancy. Contraception 55 (1997) 165-168
34. Jain J.K., Meckstroth K.R., and Michell Jr. D.R. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol. Am J Obstet Gynecol 181 (1999) 1386-1391
35. Jain J.K., Dutton C., Harwood B., Meckstroth K.R., and Michell Jr. D.R. A prospective randomized, double-blinded, placebo controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of pregnancy. Hum Reprod 17 (2002) 1477-1482
36. Carbonell J.L., Rodriguez J., Aragon S., et al. Vaginal misoprostol 1000 micrograms for early abortion. Contraception 63 (2001) 131-136
37. Von Hertzen H., Piaggio G., Nguyen T.M.H., et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet 369 (2007) 1938-1946
38. http://www.misoprostol.com.mx/index.htm. Accessed on May 10, 2008.
39. Secretaría de Salud. Hacía una política farmacéutica integral para México. 2005. Sistema Federal Sanitario: Comisíon Federal para la Protección contra Riesgos Sanitarios. http://www.cofepris.gob.mx. [accessed on May 10, 2008].
40. Maderas N.M., Landau S.C., and Taylor-McGhee B. Editorial: The continuum of care: a case for pharmacists as key members of a reproductive health team. Contraception 77 (2008) 139-142